(BIA-ALCL)

  • Definition
    • Peripheral T-Cell lymphoma associated with textured surfaces of breast implants
  • Incidence
    • Rare (1:10,000)
  • Presentation
    • Usually localised disease 10yrs post insertion
    • Seroma 60%
    • Often found incidentally during revision surgery for late-onset seroma
    • Mass 17%
  • Aetiology unknown
    • ? Implant induced chronic inflammation, ? Biofilm
    • Association with Allergan BIOCELL textured implants (91% of cases)
  • Pathology
    • Large anaplastic pleomorphic cells with abundant cytoplasm, horseshoe nuclei
    • IHC shows strong uniform CD30 staining, ALK negative
    • NB: This can also be seen in inflammation, must have anaplastic morphology and single T-Cell clone also
  • Investigations
    • USS guided aspirate of seroma and send for cytology, cultures
  • Management
    • Localised disease
      • Surgical removal of implant, associated masses/disease, and total capsulectomy
      • Treatment is usually curative
    • Disseminated disease
      • Systemic chemotherapy
    • SLNB not required, but excision biopsy of suspiciously enlarged nodes performed
    • Regular F/U
  • Prognosis
    • Biologically indolent disease with a good prognosis with complete surgical resection provided there is no extension beyond the implant capsule